封面
市場調查報告書
商品編碼
1565707

體外轉錄模板市場、按產品、按應用、按疾病類型、按國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

In-vitro Transcription Templates Market, By Product, By Application, By Disease Type, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日期: | 出版商: AnalystView Market Insights | 英文 269 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告要點

2023年體外轉錄模板市場規模為2.5143億美元,2024年至2032年複合年成長率為21.09%。

體外轉錄模板市場-市場動態

基於 RNA 的療法和疫苗的需求不斷成長以及生物技術研究的不斷增加預計也將推動市場需求

基於 RNA 的療法(包括小干擾 RNA (siRNA) 和反義寡核苷酸 (ASO))的發展增加了對高品質 RNA 生產的需求。 mRNA 疫苗,例如 Pfizer-BioNTech 和 Moderna 等針對 COVID-19 疾病開發的疫苗,顯著提高了人們對體外轉錄 (IVT) 模板的興趣。快速設計和生產 mRNA 疫苗的能力使得體外轉錄在藥物開發中變得至關重要。 CRISPR-Cas9 等基因編輯工具的興起利用體外轉錄生成嚮導 RNA (gRNA),這對於基因組編輯應用至關重要。

隨著個人化醫療的發展,為癌症免疫療法等個人化治療生產客製化 RNA 的能力推動了對高效 IVT 模板技術的需求。生物感測器、生物工程應用和新型生物電路對有效生產 RNA 的需求持續支持對轉錄模板的需求。此外,製藥和生物技術行業正在大力投資研發,這支持了對轉錄模板的需求。科學家使用體外轉錄模板來研究基因表現、蛋白質合成和細胞機制。

體外轉錄模板市場 - 關鍵見解

根據我們的研究分析師分享的分析,預計全球市場在預測期內(2024-2032)每年將以 21.09% 左右的複合年成長率成長

根據產品細分,DNA 模板細分市場預計將在 2023 年顯示最大的市場佔有率,因為它們在驅動轉錄方面效率更高。

根據應用細分,由於 COVID-19 和其他病毒感染的流行不斷增加,疫苗細分是 2023 年領先的應用細分。

根據疾病類型細分,由於肺癌、白血病、乳癌等的盛行率,癌症細分市場是 2023 年最主要的疾病類型細分市場。

從地區來看,由於政府對研究和新藥開發的支持,北美是 2023 年的主要收入來源。

體外轉錄模板市場細分分析:

全球體外轉錄模板市場根據產品、應用、疾病類型和地區進行細分。

市場依產品分為四大類:DNA模板、RNA模板、模板及轉錄試劑盒等。 DNA 模板細分市場佔據主導地位。 DNA 模板效率高,在定序和轉錄過程中穩健,有助於市場成長。

市場根據應用分為兩類:疫苗和治療劑。疫苗領域在市場上佔據主導地位。這些疫苗主要用於針對病毒感染,比其他類型的疫苗更能有效促進市場成長。

依疾病類型,市場分為五類:癌症、傳染病、遺傳性疾病、生活型態疾病等。癌症領域在市場上佔據主導地位,預計在預測期內將保持其高度主導地位。肺癌、乳癌、白血病的盛行率不斷上升,促進了細分市場的成長。

體外轉錄模板市場 - 地理洞察

從地理來看,該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲等地區。北美在全球市場中佔據最大的收入佔有率。美國憑藉其完善的生物技術和製藥行業,尤其是基於 RNA 的療法和疫苗的開發,在全球市場佔據主導地位。在亞太地區,由於其生物技術行業的不斷發展、對基於RNA的療法的投資增加以及政府對生物技術研發的支持,中國正在迅速成為IVT模板市場的主要參與者。政府對醫療保健創新的日益關注以及與全球製藥公司的合作正在推動市場發展。

體外轉錄模板市場-競爭格局:

體外轉錄 (IVT) 模板市場競爭非常激烈,生物技術和製藥行業的幾家主要參與者都專注於基於 RNA 的技術創新。這些公司正在投資開發用於 RNA 生產的高品質轉錄模板,從而推動 mRNA 疫苗、基於 RNA 的療法和基因編輯等領域的進步。主要參與者正在與製藥公司結盟,為生產基於 RNA 的疫苗和治療藥物提供關鍵的 IVT 組件。 TriLink、Aldevron 和 Merck 等公司正在大力投資擴大其製造能力,特別是高品質 RNA 生產,以滿足對 mRNA 疫苗和 RNA 藥物不斷成長的需求。

2023年9月,默克成為第一家為mRNA開發、製造、商業化和產品測試提供全面整合服務的CTDMO。

2023年,英國醫學研究委員會(MRC)和生物技術和生物科學研究委員會(BBSRC)等研究委員會為RNA生物學、基因組學的基礎和應用研究分配了大量資金。

目錄

第 1 章:體外轉錄模板市場概述

  • 研究範圍
  • 市場預估年份

第 2 章:執行摘要

  • 市場片段
    • 體外轉錄模板市場片段(依產品)
    • 體外轉錄模板市場片段(依應用)
    • 依疾病類型分類的體外轉錄模板市場片段
    • 體外轉錄模板市場片段(依國家/地區)
    • 按地區分類的體外轉錄模板市場片段
  • 競爭洞察

第 3 章:體外轉錄模板主要市場趨勢

  • 體外轉錄模板市場促進因素
    • 市場促進因素的影響分析
  • 體外轉錄模板市場限制
    • 市場限制影響分析
  • 體外轉錄模板市場機會
  • 體外轉錄模板市場未來趨勢

第 4 章:體外轉錄模板產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章:體外轉錄模板市場:COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章:體外轉錄模板市場格局

  • 2023 年體外轉錄模板市佔分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章:體外轉錄模板市場 - 按產品

  • 概述
    • 按產品分類的細分市場佔有率分析
    • DNA模板
    • RNA模板
    • 模板和轉錄套件
    • 其他

第 8 章:體外轉錄模板市場 - 按應用

  • 概述
    • 按應用分類的細分市場佔有率分析
    • 疫苗
    • 療法

第 9 章:體外轉錄模板市場 - 按疾病類型

  • 概述
    • 按疾病類型分類的細分市場佔有率分析
    • 癌症
    • 傳染病
    • 遺傳疾病 生活方式疾病
    • 其他

第 10 章:體外轉錄模板市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 體外轉錄模板北美主要製造商
    • 北美市場規模和預測(按國家)
    • 北美市場規模和預測(按產品)
    • 北美市場規模和預測(按應用)
    • 北美市場規模和預測(按疾病類型)
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 體外轉錄模板歐洲主要製造商
    • 歐洲市場規模和預測(按國家)
    • 歐洲市場規模和預測(按產品)
    • 歐洲市場規模和預測(按應用)
    • 歐洲市場規模與預測(按疾病類型)
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 體外轉錄模板亞太地區主要製造商
    • 亞太地區市場規模與預測(按國家)
    • 亞太地區市場規模與預測(按產品)
    • 亞太地區市場規模與預測(按應用)
    • 亞太地區市場規模與預測(按疾病類型)
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 體外轉錄模板拉丁美洲主要製造商
    • 拉丁美洲市場規模與預測(按國家)
    • 拉丁美洲市場規模與預測(按產品)
    • 拉丁美洲市場規模與預測(按應用)
    • 拉丁美洲市場規模與預測(按疾病類型)
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 體外轉錄模板 中東和非洲主要製造商
    • 中東和非洲市場規模及預測(按國家)
    • 中東和非洲市場規模及預測(按產品)
    • 中東和非洲市場規模及預測(按應用)
    • 中東和非洲市場規模及預測(按疾病類型)
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章:主要供應商分析 - 體外轉錄模板產業

  • 競爭儀表板
  • 公司簡介
    • Thermo Fisher Scientific
    • Merck KGaA
    • Promega Corporation
    • Agilent Technologies
    • New England Biolabs
    • Takara Bio Inc.
    • Synthego Corporation
    • TriLink BioTechnologies
    • Aldevron
    • Bio-Rad Laboratories
    • GenScript Biotech Corporation
    • Sigma-Aldrich
    • CellScript
    • QIAGEN NV
    • Lucigen Corporation
    • Others

第 12 章:360 度分析師視角

第 13 章:附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV3865

REPORT HIGHLIGHT

In-vitro Transcription Templates Market size was valued at USD 251.43 Million in 2023, expanding at a CAGR of 21.09% from 2024 to 2032.

In-vitro transcription templates are DNA sequences used to synthesize RNA in a controlled laboratory setting outside of a living organism. These templates serve as the blueprints for RNA synthesis and are essential in experiments where researchers want to produce specific RNA molecules.

In-vitro Transcription Templates Market- Market Dynamics

Growing demand from RNA-based therapeutics & vaccines and increasing research in biotech is also expected to propel market demand

The development of RNA-based therapeutics, including small interfering RNA (siRNA) and antisense oligonucleotides (ASOs), has increased demand for high-quality RNA production. mRNA vaccines, like those developed for COVID-19 disease like Pfizer-BioNTech and Moderna, have significantly boosted interest in in-vitro transcription (IVT) templates. The ability to rapidly design and produce mRNA vaccines has made in-vitro transcription crucial in pharmaceutical development. The rise of gene-editing tools like CRISPR-Cas9 uses in-vitro transcription to generate guide RNA (gRNA), which is critical for genome editing applications.

As personalized medicine evolves, the ability to produce tailor-made RNA for individualized treatments like cancer immunotherapies drives the demand for efficient IVT template technology. The need for efficient production of RNA for biosensors, bioengineering applications, and novel biological circuits continues to support the demand for transcription templates. In addition, the pharmaceutical and biotechnology industries are investing heavily in R&D, which supports the demand for transcription templates. Scientists use in-vitro transcription templates to study gene expression, protein synthesis, and cellular mechanisms.

In-vitro Transcription Templates Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 21.09% over the forecast period (2024-2032)

Based on Product segmentation, the DNA templates segment was predicted to show maximum market share in the year 2023, owing to their higher efficiency in driving transcription.

Based on Application segmentation, vaccines segment was the leading Application segment in 2023, due to the growing prevalence of COVID-19 and other viral infections.

Based on Disease Type segmentation, cancer segment was the leading Disease Type segment in 2023, due to prevalence of lung cancer, leukemia, breast cancer, etc.

On the basis of region, North America was the leading revenue generator in 2023, due to the government support in research & new drugs development.

In-vitro Transcription Templates Market- Segmentation Analysis:

The Global In-vitro Transcription Templates Market is segmented on the basis of Product, Application, Disease Type, and Region.

The market is divided into four categories based on Product: DNA templates, RNA templates, templates & transcription kits, and others. The DNA templates segment dominates the market. DNA templates offer high efficiency & are robust in sequencing & transcription process which is contributing to market growth.

The market is divided into two categories based on Application: vaccines and therapeutics. The vaccines segment dominates the market. The vaccines are mainly used in targeting viral infections and are more effective than other type boosting market growth.

The market is divided into five categories based on Disease Type: cancer, infectious diseases, genetic diseases lifestyle diseases, and others. The cancer segment dominates the market and is expected to maintain its high dominance during the forecast period. The growing prevalence of lung, breast cancer, leukemia are supplementing segment growth.

In-vitro Transcription Templates Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America held the largest revenue share in the global market. The U.S. dominates the global market due to its well-established biotechnology and pharmaceutical sectors, particularly in the development of RNA-based therapies and vaccines. In Asia Pacific, China is rapidly emerging as a key player in the IVT template market due to its growing biotech sector, increasing investments in RNA-based therapeutics, and government support for biotechnology R&D. Increased government focus on healthcare innovation and collaborations with global pharma companies are driving the market.

In-vitro Transcription Templates Market- Competitive Landscape:

The In-vitro Transcription (IVT) Templates market is significantly competitive, with several key players across the biotechnology and pharmaceutical industries focusing on innovations in RNA-based technologies. These companies are investing in developing high-quality transcription templates for RNA production, enabling advancements in areas like mRNA vaccines, RNA-based therapeutics, and gene editing. Key players are forming alliances with pharmaceutical companies to supply critical IVT components for the production of RNA-based vaccines and therapeutics. Companies like TriLink, Aldevron, and Merck are heavily investing in expanding their manufacturing capabilities, particularly for high-quality RNA production, to meet the growing demand for mRNA vaccines and RNA-based drugs.

In September 2023, Merck became the first CTDMO to offer fully integrated services for mRNA development, manufacturing, commercialization, and product testing.

In 2023, UK research councils such as the Medical Research Council (MRC) and the Biotechnology and Biological Sciences Research Council (BBSRC) allocated substantial funding for basic and applied research in RNA biology, genomics.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL IN-VITRO TRANSCRIPTION TEMPLATES MARKET KEY PLAYERS

  • Thermo Fisher Scientific
  • Merck KGaA
  • Promega Corporation
  • Agilent Technologies
  • New England Biolabs
  • Takara Bio Inc.
  • Synthego Corporation
  • TriLink BioTechnologies
  • Aldevron
  • Bio-Rad Laboratories
  • GenScript Biotech Corporation
  • Sigma-Aldrich
  • CellScript
  • QIAGEN N.V.
  • Lucigen Corporation
  • Others

GLOBAL IN-VITRO TRANSCRIPTION TEMPLATES MARKET, BY PRODUCT- MARKET ANALYSIS, 2019-2032

  • DNA templates
  • RNA templates
  • Templates & Transcription Kits
  • Others

GLOBAL IN-VITRO TRANSCRIPTION TEMPLATES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032

  • Vaccines
  • Therapeutics

GLOBAL IN-VITRO TRANSCRIPTION TEMPLATES MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2019-2032

  • Cancer
  • Infectious diseases
  • Genetic diseases lifestyle diseases
  • Others

GLOBAL IN-VITRO TRANSCRIPTION TEMPLATES MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. In-vitro Transcription Templates Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. In-vitro Transcription Templates Market Snippet by Product
    • 2.1.2. In-vitro Transcription Templates Market Snippet by Application
    • 2.1.3. In-vitro Transcription Templates Market Snippet by Disease Type
    • 2.1.4. In-vitro Transcription Templates Market Snippet by Country
    • 2.1.5. In-vitro Transcription Templates Market Snippet by Region
  • 2.2. Competitive Insights

3. In-vitro Transcription Templates Key Market Trends

  • 3.1. In-vitro Transcription Templates Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. In-vitro Transcription Templates Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. In-vitro Transcription Templates Market Opportunities
  • 3.4. In-vitro Transcription Templates Market Future Trends

4. In-vitro Transcription Templates Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. In-vitro Transcription Templates Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. In-vitro Transcription Templates Market Landscape

  • 6.1. In-vitro Transcription Templates Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. In-vitro Transcription Templates Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
    • 7.1.2. DNA templates
    • 7.1.3. RNA templates
    • 7.1.4. Templates & Transcription Kits
    • 7.1.5. Others

8. In-vitro Transcription Templates Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Vaccines
    • 8.1.3. Therapeutics

9. In-vitro Transcription Templates Market - By Disease Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Disease Type, 2024 & 2032 (%)
    • 9.1.2. Cancer
    • 9.1.3. Infectious diseases
    • 9.1.4. Genetic diseases lifestyle diseases
    • 9.1.5. Others

10. In-vitro Transcription Templates Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. In-vitro Transcription Templates Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. In-vitro Transcription Templates Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. In-vitro Transcription Templates Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. In-vitro Transcription Templates Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. In-vitro Transcription Templates Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- In-vitro Transcription Templates Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Thermo Fisher Scientific
    • 11.2.2. Merck KGaA
    • 11.2.3. Promega Corporation
    • 11.2.4. Agilent Technologies
    • 11.2.5. New England Biolabs
    • 11.2.6. Takara Bio Inc.
    • 11.2.7. Synthego Corporation
    • 11.2.8. TriLink BioTechnologies
    • 11.2.9. Aldevron
    • 11.2.10. Bio-Rad Laboratories
    • 11.2.11. GenScript Biotech Corporation
    • 11.2.12. Sigma-Aldrich
    • 11.2.13. CellScript
    • 11.2.14. QIAGEN N.V.
    • 11.2.15. Lucigen Corporation
    • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us